Pharmokinetics II Flashcards

1
Q

Can the loading dose change the time it takes to reach the steady state?

A

NO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the loading dose?

A

It is a “start-up” dose that is used to reach the therapeutic level more rapidly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the primary determinant of the maintenance dose?

A

Clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the target for the loading dose?

A

The peak therapeutic concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is elimination clearance?

A

Irreversible drug removal from the plasma through an eliminating organ(s).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Do higher doses achieve the steady state faster?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is 1st order elimination?

A

The elimination rate of the drug is a constant fraction of the drug remaining in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is 0 order elimination?

A

A fixed amount of drug is metabolized per unit time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some drugs that follow 1st order elimination?

A

Most clinical drugs do

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some drugs that follow 0 order elimination?

A

Ethanol

Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is dose dependent elimination?

A

It is 1st order if Km far greater than C and 0 order if Km far less than C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A patient with grand mal seizures is receiving phenytoin 300 mg po per day. The phenytoin plasma level is 9.5 􏰀g/ml (therapeutic range 10-20 􏰀g/ml). The dose of phenytoin is increased to 500 mg po per day and one week later the patient presents with lethargy and ataxia. A repeat phenytoin plasma level is now 30 􏰀g/ml. Which of the following best explains this clinical picture?

A) Phenytoin follows first-order kinetics of elimination.
B) The bioavailability of phenytoin has decreased.
C) Saturation of metabolic pathways resulted in toxic
levels.
D) The Vmax for phenytoin metabolism has increased.
E) The renal clearance of phenytoin has decreased.

A

C) Saturation of metabolic pathways resulted in toxic

levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which of the following is true when a drug exhibits zero-order kinetics of elimination?

A) A constant fraction of the drug is eliminated per unit time.
B) A constant fraction of the volume of distribution is cleared of drug.
C) A constant amount of drug is eliminated per unit time.
D) A constant half-life of elimination is observed.
E) A constant oral bioavailability is seen regardless of the dose.

A

C) A constant amount of drug is eliminated per unit time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which of the following is considered a “primary” pharmacokinetic parameter?

A)The loading dose
B)The elimination half-life 
C)The elimination clearance 
D)The Vmax and the Km
E) The infusion rate
A

C) The elimination clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the time to reach the steady state dependent upon?

A

The half life of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the primary pharmokinetic parameters?

A

Clearance (CL)

Volume of Distribution (Vd)

17
Q

Propranolol has a half-life of elimination (t1⁄2) of 4 hours and is prescribed to a patient at a dose of 20 mg orally every 6 hours. How long will it take to reach 90% of the steady-state plasma level with continuous therapy?

A. 6 hours 
B. 9 hours 
C. 13 hours 
D. 18 hours 
E. 26 hours
A

C. 13 hours

18
Q

In cases of renal insufficiency, how can the dose rate be adjusted?

A
  • Reducing the dose

- Increasing the dosing interval

19
Q

What are the determinants of hepatic drug clearance?

A
  1. Hepatic Blood Flow
    (Rate of drug delivery to the eliminating organ)
  2. Plasma Protein Binding (Fraction of drug available for clearance)
  3. Intrinsic Clearance
    (Hepatocellular metabolism and/or biliary excretion)
20
Q

What is the most important determinant in restrictive hepatic clearance?

A

Drug binding or drug metabolism/excretion

21
Q

What is the most important determinant in non-restrictive hepatic clearance?

A

Blood flow